for the bio-sciences sector
Scientists present ground breaking research in models of Acute Kidney Injury (AKI). Methods used to gather these insights are made possible using the latest in fibre optic sensing technology by Oxford Optronix Ltd. to obtain dissolved oxygen and microvascular blood perfusion at the tissue level.
WellBeing™ clinical trials commence
Happy New Year!
Ed Vaizey MP visits Oxford Optronix
Welcome to our new website!
Spring has sprung
Reflecting on 2016; looking forward to 2017
A little time Down Under…
Latest GelCount software update
Asia distributor workshop
Performance updates for HypoxyLab
Meet us at Genes & Cancer UK, Cambridge
Looking forward to a busy 2015
Oxford Optronix reaches new customers
Strategic tie-up with SciPro Inc., USA
Single-channel OxyFlo™ now shipping
GelCount™ software update
Reflections on 2013
Autumn conference round-up
Our 2013 Customer Survey results are out
Next-generation OxyLite™ and OxyFlo™ monitors